NEA Management Company as of Dec. 31, 2020
Portfolio Holdings for NEA Management Company
NEA Management Company holds 57 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Desktop Metal Com Cl A (DM) | 12.9 | $489M | 28M | 17.20 | |
| Allakos (ALLK) | 8.0 | $303M | 2.2M | 140.00 | |
| Eargo | 7.7 | $292M | 6.5M | 44.82 | |
| Crispr Therapeutics Namen Akt (CRSP) | 6.4 | $243M | 1.6M | 153.11 | |
| Cloudflare Cl A Com (NET) | 5.6 | $212M | 2.8M | 76.70 | |
| Nkarta (NKTX) | 4.7 | $179M | 2.9M | 61.47 | |
| Opendoor Technologies (OPEN) | 4.0 | $152M | 6.7M | 22.73 | |
| Rhythm Pharmaceuticals (RYTM) | 3.8 | $143M | 4.9M | 29.10 | |
| Sprout Social Com Cl A (SPT) | 3.7 | $140M | 3.1M | 45.41 | |
| Oyster Point Pharma | 2.9 | $112M | 5.9M | 18.82 | |
| Black Diamond Therapeutics (BDTX) | 2.9 | $111M | 3.4M | 32.05 | |
| Palo Alto Networks (PANW) | 2.5 | $96M | 269k | 355.39 | |
| Adaptimmune Therapeutics Adr (ADAP) | 2.4 | $92M | 17M | 5.39 | |
| Imara | 2.3 | $89M | 4.0M | 22.05 | |
| Ardelyx (ARDX) | 2.3 | $88M | 14M | 6.47 | |
| Akouos | 2.3 | $85M | 4.3M | 19.83 | |
| Trillium Therapeutics Com New | 2.2 | $84M | 5.7M | 14.71 | |
| Mirum Pharmaceuticals (MIRM) | 1.9 | $73M | 4.2M | 17.46 | |
| Aurinia Pharmaceuticals (AUPH) | 1.9 | $72M | 5.2M | 13.83 | |
| Annexon (ANNX) | 1.7 | $63M | 2.5M | 25.03 | |
| Inozyme Pharma (INZY) | 1.3 | $51M | 2.4M | 20.64 | |
| Galera Therapeutics (GRTX) | 1.2 | $45M | 4.4M | 10.23 | |
| Casper Sleep | 1.0 | $38M | 6.2M | 6.15 | |
| Bloom Energy Corp Com Cl A (BE) | 1.0 | $38M | 1.3M | 28.66 | |
| Verona Pharma Ads (VRNA) | 0.9 | $36M | 5.1M | 7.00 | |
| Affimed Therapeutics B V | 0.9 | $36M | 6.1M | 5.82 | |
| Glycomimetics (GLYC) | 0.9 | $34M | 9.1M | 3.76 | |
| Genocea Biosciences (GNCAQ) | 0.7 | $25M | 10M | 2.42 | |
| Metacrine Ord | 0.6 | $24M | 3.1M | 7.86 | |
| Upstart Hldgs (UPST) | 0.6 | $23M | 573k | 40.75 | |
| Cti Biopharma Corp Com New | 0.6 | $23M | 7.1M | 3.22 | |
| Aveo Pharmaceuticals | 0.6 | $23M | 4.0M | 5.77 | |
| Mei Pharma Com New | 0.6 | $23M | 8.5M | 2.64 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.6 | $22M | 6.6M | 3.36 | |
| Geron Corporation (GERN) | 0.6 | $21M | 14M | 1.59 | |
| Lumos Pharma (LUMO) | 0.5 | $19M | 527k | 35.71 | |
| Champions Oncology Com New (CSBR) | 0.5 | $19M | 1.7M | 10.79 | |
| Vistagen Therapeutics | 0.5 | $18M | 9.4M | 1.94 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $15M | 992k | 15.38 | |
| Inventiva Sa Ads (IVA) | 0.4 | $15M | 1.0M | 14.50 | |
| DZS (DZSI) | 0.4 | $15M | 956k | 15.47 | |
| Trevi Therapeutics (TRVI) | 0.4 | $14M | 5.9M | 2.42 | |
| Strongbridge Biopharma Shs Usd | 0.3 | $10M | 4.1M | 2.43 | |
| Senseonics Hldgs (SENS) | 0.3 | $10M | 12M | 0.87 | |
| Obseva Sa | 0.3 | $9.5M | 4.6M | 2.08 | |
| Synlogic | 0.2 | $9.1M | 4.2M | 2.16 | |
| Regulus Therapeutics Com New | 0.2 | $8.7M | 6.5M | 1.35 | |
| Trevena | 0.2 | $8.2M | 3.8M | 2.14 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.2 | $8.1M | 2.4M | 3.42 | |
| Liquidia Technologies (LQDA) | 0.2 | $7.3M | 2.5M | 2.95 | |
| Marker Therapeutics Ord | 0.2 | $7.3M | 5.0M | 1.45 | |
| Erytech Pharma Sa Adr | 0.2 | $5.8M | 625k | 9.23 | |
| Tracon Pharmaceuticals (TCON) | 0.1 | $4.1M | 347k | 11.70 | |
| Millendo Therapeutics | 0.1 | $3.8M | 1.8M | 2.14 | |
| Palantir Technologies Cl A (PLTR) | 0.0 | $1.4M | 60k | 23.56 | |
| Akari Therapeutics Adr | 0.0 | $837k | 452k | 1.85 | |
| Sunesis Pharmaceuticals Com Par | 0.0 | $258k | 130k | 1.99 |
